Is HUN a Buy or a Sell? The Bull and Bear Case (2026)
Last updated July 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Huntsman Corporation (HUN) rests on Pending Olin merger: In June 2026 Huntsman agreed to an all-stock merger of equals with Olin, with Huntsman holders set to receive about 0.5476 Olin shares per Huntsman share and to own roughly 45.5 percent of the combined 'OlinHuntsman.' The deal is pitched as creating a vertically integrated North American chemicals leader with more than $12 billion of revenue and over $400 million of targeted cost synergies. The bear case rests on huntsman is deeply cyclical and was loss-making in 2025 and early 2026, with net debt leverage around 6.1x and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet. Analysts covering it publish targets from $11.00 to $18.00 against a $11.55 price, so even the professionals disagree by 52% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Huntsman Corporation is a global manufacturer of differentiated and specialty chemicals organized into three segments: Polyurethanes (MDI, polyols and TPU used in insulation, automotive seating, adhesives, coatings and footwear), Performance Products (amines, surfactants and maleic anhydride for agriculture, energy, personal care and construction), and Advanced Materials (epoxy, phenoxy, acrylic and polyurethane formulations for aerospace, electronics and industrial uses). It is roughly the fourth-largest MDI producer worldwide, behind Wanhua Chemical, BASF and Covestro. The investment picture is defined by a deep chemicals downcycle and a pending combination. Full-year 2025 revenue fell to about $5.7 billion with a net loss of roughly $275 million, and Q1 2026 stayed in the red as MDI margins, weak construction and automotive demand, and Chinese low-cost capacity pressured results. Net debt leverage climbed to about 6.1x, the dividend was cut, and credit ratings were lowered to below investment grade. In June 2026 Huntsman agreed to merge with Olin in an all-stock deal, so the shares now trade heavily on the exchange ratio, deal completion odds and expected synergies rather than standalone fundamentals alone.
The bull case: what would have to be true for $18.00
The most optimistic published target on HUN is $18.00, +55.8% from the $11.55 price as of July 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Pending Olin merger
In June 2026 Huntsman agreed to an all-stock merger of equals with Olin, with Huntsman holders set to receive about 0.5476 Olin shares per Huntsman share and to own roughly 45.5 percent of the combined 'OlinHuntsman.' The deal is pitched as creating a vertically integrated North American chemicals leader with more than $12 billion of revenue and over $400 million of targeted cost synergies. Until it closes, HUN largely tracks Olin's share price and the market's confidence in the deal.
2. Polyurethanes and MDI cycle
Polyurethanes is the largest segment and its earnings swing with MDI margins, which have been depressed by soft construction and automotive demand and by aggressive Chinese capacity additions. Q1 2026 showed about 4 percent year-over-year volume growth in Polyurethanes, including some European improvement, so a cyclical recovery in MDI pricing would be a meaningful lever if demand firms.
3. Advanced Materials and aerospace
Advanced Materials has been a relative bright spot, with revenues growing over 10 percent year over year in Q1 2026 as sales into aerospace increased. Higher-value formulation and specialty applications carry better margins than commodity polyurethanes and offer some ballast against the MDI cycle.
4. Cost cuts and self-help
Management has leaned on restructuring, plant closings and cost reduction to protect cash flow while end markets stay weak. These programs, plus the synergy case behind the Olin merger, are the main drivers of any earnings improvement independent of a broad chemicals recovery, though restructuring charges have also weighed on reported results.
The bear case: what would have to be true for $11.00
The most pessimistic published target is $11.00, -4.8% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Huntsman Corporation is worth if the risks below bite instead of the drivers above.
Huntsman is deeply cyclical and was loss-making in 2025 and early 2026, with net debt leverage around 6.1x and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet. The dividend was reduced sharply and is not guaranteed. The Olin merger introduces deal risk: it requires shareholder and regulatory approvals and could be delayed or blocked, and because it is all-stock the value received depends on Olin's share price. Low-cost Chinese MDI capacity, weak construction and automotive demand, and volatile feedstock costs such as benzene and European natural gas can all pressure margins further.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding HUN already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on HUN
12 analysts cover HUN, with an average target of $13.58 (+17.6% against $11.55) and a split of 1 buy, 10 hold, 2 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the HUN forecast and price target page.
How is HUN valued? (as of JULY 2026)
Snapshot for HUN as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (FY2025): ~$5.7B
- Revenue (Q1 2026): ~$1.42B
- Net loss (FY2025): ~$275M
- Diluted EPS (FY2025): ~-$1.59
- Market cap: ~$1.8-2.4B
- Net debt leverage: ~6.1x
Huntsman is currently unprofitable on a trailing basis, so a positive P/E is not meaningful and investors lean on revenue, EBITDA and leverage. As of mid-2026 the stock traded around $10 to $11 with a 52-week range of roughly $7.30 to $16, and the dividend yield screened high partly because the price had fallen. With a merger agreed, valuation is best read against the Olin exchange ratio rather than standalone multiples.
How do you decide if HUN is a buy?
Rather than asking whether HUN is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold HUN indirectly through an index or sector ETF before adding more.
What would change your mind on HUN
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Pending Olin merger stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: huntsman is deeply cyclical and was loss-making in 2025 and early 2026, with net debt leverage around 6.1x and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the HUN stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about HUN against your real portfolio and see your actual exposure before deciding.
Investing in Huntsman Corporation with AI
Connect the broker you already use and ask Walnut's AI how HUN fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is HUN a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Pending Olin merger, with revenue (fy2025) at ~$5.7B. The bear case rests on huntsman is deeply cyclical and was loss-making in 2025 and early 2026, with net debt leverage around 6.1x and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet. Analysts covering it are spread from $11.00 to $18.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell HUN?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Huntsman is deeply cyclical and was loss-making in 2025 and early 2026, with net debt leverage around 6.1x and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $11.00, -4.8% from the $11.55 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for HUN?
+
Pending Olin merger. In June 2026 Huntsman agreed to an all-stock merger of equals with Olin, with Huntsman holders set to receive about 0.5476 Olin shares per Huntsman share and to own roughly 45.5 percent of the combined 'OlinHuntsman.' The deal is pitched as creating a vertically integrated North American chemicals leader with more than $12 billion of revenue and over $400 million of targeted cost synergies. The most optimistic analyst target on HUN is $18.00, +55.8% from the $11.55 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for HUN?
+
Huntsman is deeply cyclical and was loss-making in 2025 and early 2026, with net debt leverage around 6.1x and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet. The dividend was reduced sharply and is not guaranteed. The Olin merger introduces deal risk: it requires shareholder and regulatory approvals and could be delayed or blocked, and because it is all-stock the value received depends on Olin's share price. Low-cost Chinese MDI capacity, weak construction and automotive demand, and volatile feedstock costs such as benzene and European natural gas can all pressure margins further. The most pessimistic published target is $11.00, -4.8% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Huntsman Corporation do?
+
Huntsman Corporation is a global manufacturer of differentiated and specialty chemicals organized into three segments: Polyurethanes (MDI, polyols and TPU used in insulation, autom
What would have to change for HUN to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Pending Olin merger) stalling in the reported numbers rather than in the narrative, the risk above (huntsman is deeply cyclical and was loss-making in 2025 and early 2026, with net debt leverage around 6.1x and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Huntsman Corporation do?
+
Huntsman manufactures differentiated and specialty chemicals across three segments: Polyurethanes (MDI, polyols, TPU), Performance Products (amines, surfactants, maleic anhydride) and Advanced Materials (epoxy and other formulations). Its products go into insulation, automotive, adhesives, coatings, aerospace, agriculture and construction.
Is Huntsman being acquired?
+
In June 2026 Huntsman agreed to an all-stock merger of equals with Olin Corporation. Huntsman holders would receive about 0.5476 Olin shares per share and own roughly 45.5 percent of the combined company, to be called OlinHuntsman. The deal remains subject to shareholder and regulatory approvals.
Why is Huntsman losing money?
+
A deep chemicals downcycle has hit Huntsman, with weak construction, automotive, aerospace and electronics demand, lower MDI margins, and low-cost Chinese capacity pressuring prices. FY2025 revenue fell to about $5.7 billion and it posted a net loss of roughly $275 million, with losses continuing into early 2026.
Walnut is informational, not investment advice, and gives no verdict on HUN. Analyst targets referenced here come from a July 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.